Condition
High Altitude
ClinicalTrials.gov condition label
Clinical trials
17 shownAssessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAHNCT07804576 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAHNCT07797166 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy IndividualsNCT07797088 · 2026-09-25
NOT_YET_RECRUITINGSleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Healthy Individuals HNCT07801950 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Healthy Individuals HNCT07801872 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAHNCT07801859 · 2026-09-25
NOT_YET_RECRUITINGSleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHNCT07801963 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Healthy Individuals HNCT07801846 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy IndividualsNCT07804589 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Healthy IndividualsNCT07804537 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals HNCT07804485 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHNCT07804472 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHNCT07804524 · 2026-09-25
NOT_YET_RECRUITINGAssessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAHNCT07804693 · 2026-09-25
NOT_YET_RECRUITINGCardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High AltitudeNCT05063643 · 2021-10-01
UNKNOWNHypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT04915378 · 2021-06-01
COMPLETEDHIGH Altitude CArdiovascular REsearch in the ANDESNCT01830530 · 2012-05-01
COMPLETEDCommon interventions
Descent from 2850m to sea levelBEHAVIORAL4Re-ascent from sea level to 2850mBEHAVIORAL4Descent and re-ascent (2850m, sea level)BEHAVIORAL2Re-Ascent sea level to 2850mBEHAVIORAL2Descent from 2850m to sea level and re-ascent back to 2850mBEHAVIORAL1Descent to sea levelBEHAVIORAL1High altitudeOTHER1High Altitude (3100m)PROCEDURE1hypoxia altitude simulation test (HAST) at 760mOTHER1NifedipineDRUG1placeboDRUG1TelmisartanDRUG1
Leading sponsors
Trial status mix
NOT_YET_RECRUITING14
COMPLETED2
UNKNOWN1
Phase mix
NA14
PHASE41
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.